NFKB1 and adenomyosis: Feng et al. found that rhein could down-regulate and suppress the expression of p-p65, p-AKT, and active Rac1 to inhibit NF-κB and β-Catenin signaling pathways, thereby ameliorating the treatment of uterine adenomyosis [32].